Next Article in Journal
Effect of Nano-Reinforcement Topologies on the Viscoelastic Performance of Carbon Nanotube/Carbon Fiber Hybrid Composites
Next Article in Special Issue
Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates
Previous Article in Journal
Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein
Previous Article in Special Issue
Superparamagnetic Iron Oxide Nanoparticles Modified with Silica Layers as Potential Agents for Lung Cancer Treatment
Open AccessArticle

Solid Plasmonic Substrates for Breast Cancer Detection by Means of SERS Analysis of Blood Plasma

Faculty of Physics, “Babeș-Bolyai” University, M. Kogalniceanu 1, 400084 Cluj-Napoca, Romania
MedFuture Research Center for Advance Medicine, “Iuliu Hațieganu” University of Medicine and Pharmacy, L. Pasteur 4-6, 400349 Cluj-Napoca, Romania
Department of Senology, The Oncology Institute “Prof. Dr. Ion Chiricuta”, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania
Department of Dental Propedeutics and Esthetics, “Iuliu Hațieganu” University of Medicine and Pharmacy, 8 V. Babes Street, 400012 Cluj-Napoca, Romania
Department of Chemistry, Wright State University, 3640 Colonel Glenn Hwy., Dayton, OH 45435-0001, USA
Department of Pharmaceutical Physics-Biophysics, “Iuliu Hațieganu” University of Medicine and Pharmacy, L. Pasteur 6, 400349 Cluj-Napoca, Romania
Authors to whom correspondence should be addressed.
These authors equally contributed to this paper.
Nanomaterials 2020, 10(6), 1212;
Received: 11 May 2020 / Revised: 10 June 2020 / Accepted: 17 June 2020 / Published: 21 June 2020
(This article belongs to the Special Issue Application of Nanoscale Materials for Cancer Diagnostic and Therapy)
Surface enhanced Raman spectroscopy (SERS) represents a promising technique in providing specific molecular information that could have a major impact in biomedical applications, such as early cancer detection. SERS requires the presence of a suitable plasmonic substrate that can generate enhanced and reproducible diagnostic relevant spectra. In this paper, we propose a new approach for the synthesis of such a substrate, by using concentrated silver nanoparticles purified using the Tangential Flow Filtration method. The capacity of our substrates to generate reproducible and enhanced Raman signals, in a manner that can allow cancer detection by means of Multivariate Analysis (MVA) of Surface Enhanced Raman (SER) spectra, has been tested on blood plasma samples collected from 35 healthy donors and 29 breast cancer patients. All the spectra were analyzed by a combined Principal Component-Linear Discriminant Analysis. Our results facilitated the discrimination between healthy donors and breast cancer patients with 90% sensitivity, 89% specificity and 89% accuracy. This is a direct consequence of substrates’ ability to generate diagnostic relevant spectral information by performing SERS measurements on pristine blood plasma samples. Our results suggest that this type of solid substrate could be employed for the detection of other types of cancer or other diseases by means of MVA-SERS procedure. View Full-Text
Keywords: SERS; solid plasmonic substrates; biofluids; MVA-SERS based cancer detection SERS; solid plasmonic substrates; biofluids; MVA-SERS based cancer detection
Show Figures

Graphical abstract

MDPI and ACS Style

Știufiuc, G.F.; Toma, V.; Buse, M.; Mărginean, R.; Morar-Bolba, G.; Culic, B.; Tetean, R.; Leopold, N.; Pavel, I.; Lucaciu, C.M.; Știufiuc, R.I. Solid Plasmonic Substrates for Breast Cancer Detection by Means of SERS Analysis of Blood Plasma. Nanomaterials 2020, 10, 1212.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop